Provided by Tiger Trade Technology Pte. Ltd.

Amneal Pharmaceuticals, Inc.

15.19
+0.37002.50%
Post-market: 15.490.3000+1.97%17:28 EST
Volume:2.70M
Turnover:41.10M
Market Cap:4.78B
PE:944.01
High:15.42
Open:14.90
Low:14.85
Close:14.82
52wk High:15.42
52wk Low:6.69
Shares:314.36M
Float Shares:168.50M
Volume Ratio:1.72
T/O Rate:1.60%
Dividend:- -
Dividend Rate:- -
EPS(TTM):0.0161
EPS(LYR):-0.3783
ROE:-881.26%
ROA:6.79%
PB:-43.63
PE(LYR):-40.15

Loading ...

Feb 03, 2026

Major Issues Report

Form 8-K - Current report
Jan 29, 2026

Major Issues Report

Form 8-K - Current report
Jan 13, 2026

Major Issues Report

Form 8-K - Current report
Nov 17, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Oct 30, 2025

Major Issues Report

Form 8-K - Current report
Aug 27, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 22, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 20, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 15, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 13, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 12, 2025

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]